Hyperfine Inc is a medical device company that created Swoop... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OILD | 29.48 | 0.60 | +2.08% |
| MicroSectors Oil & Gas Exp. & Prod. - 3x Inverse Leveraged ETN (OILD) | |||
| PSMJ | 34.49 | N/A | N/A |
| Pacer Swan SOS Moderate (July) ETF (PSMJ) | |||
| REGL | 86.65 | -1.14 | -1.30% |
| ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) | |||
| BPI | 25.74 | -0.45 | -1.73% |
| Grayscale Bitcoin Premium Income ETF | |||
| FXZ | 76.81 | -2.03 | -2.57% |
| First Trust Materials AlphaDEX Fund (FXZ) | |||
A.I.dvisor indicates that over the last year, HYPR has been loosely correlated with BFLY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPR jumps, then BFLY could also see price increases.
| Ticker / NAME | Correlation To HYPR | 1D Price Change % | ||
|---|---|---|---|---|
| HYPR | 100% | -2.41% | ||
| BFLY - HYPR | 37% Loosely correlated | -4.94% | ||
| QSI - HYPR | 37% Loosely correlated | +4.92% | ||
| SGHT - HYPR | 33% Loosely correlated | -1.05% | ||
| TMCI - HYPR | 28% Poorly correlated | -2.75% | ||
| NXL - HYPR | 28% Poorly correlated | -4.00% | ||
More | ||||
| Ticker / NAME | Correlation To HYPR | 1D Price Change % |
|---|---|---|
| HYPR | 100% | -2.41% |
| Medical/Nursing Services industry (140 stocks) | 1% Poorly correlated | -1.27% |
| Health Services industry (240 stocks) | -0% Poorly correlated | -0.80% |
Industry MedicalNursingServices
HYPR saw its Momentum Indicator move above the 0 level on September 24, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 105 similar instances where the indicator turned positive. In 94 of the 105 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HYPR's RSI Indicator exited the oversold zone, 27 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +10.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where HYPR advanced for three days, in 178 of 220 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 41 cases where HYPR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
HYPR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HYPR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
HYPR broke above its upper Bollinger Band on October 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HYPR entered a downward trend on September 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.411) is normal, around the industry mean (10.853). P/E Ratio (0.000) is within average values for comparable stocks, (98.910). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (4.340) is also within normal values, averaging (39.828).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. HYPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HYPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.